| abstract |
The present invention relates to transdermal dosage form (FIG. 1 - 3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form (FIG. 1 - 3 ) releases the inactivating agent upon disruption of the dosage form (FIG. 1 - 3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form (FIG. 1 - 3 ). |